Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Total Current Liabilities: 2022-2024

Historic Total Current Liabilities for Gossamer Bio (GOSS) over the last 3 years, with Dec 2024 value amounting to $45.0 million.

  • Gossamer Bio's Total Current Liabilities rose 21.60% to $62.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.1 million, marking a year-over-year increase of 21.60%. This contributed to the annual value of $45.0 million for FY2024, which is 12.77% down from last year.
  • Latest data reveals that Gossamer Bio reported Total Current Liabilities of $45.0 million as of FY2024, which was down 12.77% from $51.6 million recorded in FY2023.
  • In the past 5 years, Gossamer Bio's Total Current Liabilities ranged from a high of $51.6 million in FY2023 and a low of $45.0 million during FY2024.
  • For the 3-year period, Gossamer Bio's Total Current Liabilities averaged around $48.6 million, with its median value being $49.2 million (2022).
  • Per our database at Business Quant, Gossamer Bio's Total Current Liabilities grew by 4.81% in 2023 and then decreased by 12.77% in 2024.
  • Yearly analysis of 3 years shows Gossamer Bio's Total Current Liabilities stood at $49.2 million in 2022, then increased by 4.81% to $51.6 million in 2023, then fell by 12.77% to $45.0 million in 2024.